Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:38 UTC |
---|
HMDB ID | HMDB0014498 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Buclizine |
---|
Description | Buclizine is only found in individuals that have used or taken this drug. It is an antihistamine of the piperazine derivative family. [Wikipedia ]Vomiting (emesis) is essentially a protective mechanism for removing irritant or otherwise harmful substances from the upper GI tract. Emesis or vomiting is controlled by the vomiting centre in the medulla region of the brain, an important part of which is the chemotrigger zone (CTZ). The vomiting centre possesses neurons which are rich in muscarinic cholinergic and histamine containing synapses. These types of neurons are especially involved in transmission from the vestibular apparatus to the vomiting centre. Motion sickness principally involves overstimulation of these pathways due to various sensory stimuli. Hence the action of buclizine which acts to block the histamine receptors in the vomiting centre and thus reduce activity along these pathways. Furthermore since buclizine possesses anti-cholinergic properties as well, the muscarinic receptors are similarly blocked. |
---|
Structure | CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)C=C1 InChI=1S/C28H33ClN2/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24/h4-16,27H,17-21H2,1-3H3 |
---|
Synonyms | Value | Source |
---|
1-(p-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine | ChEBI | Buclizina | ChEBI | Buclizinum | ChEBI | Buclina | Kegg | 1-(p-Tert-butylbenzyl)-4-(4-chloro-a-phenylbenzyl)piperazine | Generator | 1-(p-Tert-butylbenzyl)-4-(4-chloro-α-phenylbenzyl)piperazine | Generator | 1-((4-Chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)piperazine | MeSH, HMDB | Softran | MeSH, HMDB | Stuart brand 1 OF buclizine dihydrochloride | MeSH, HMDB | Stuart brand 2 OF buclizine dihydrochloride | MeSH, HMDB | Buclizine dihydrochloride | MeSH, HMDB | Aphilan | MeSH, HMDB | Bucladin-S | MeSH, HMDB | Buclizine hydrochloride | MeSH, HMDB |
|
---|
Chemical Formula | C28H33ClN2 |
---|
Average Molecular Weight | 433.028 |
---|
Monoisotopic Molecular Weight | 432.233226773 |
---|
IUPAC Name | 1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)(phenyl)methyl]piperazine |
---|
Traditional Name | buclizine |
---|
CAS Registry Number | 82-95-1 |
---|
SMILES | CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)C=C1 |
---|
InChI Identifier | InChI=1S/C28H33ClN2/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24/h4-16,27H,17-21H2,1-3H3 |
---|
InChI Key | MOYGZHXDRJNJEP-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Diphenylmethanes |
---|
Direct Parent | Diphenylmethanes |
---|
Alternative Parents | |
---|
Substituents | - Diphenylmethane
- Phenylpropane
- Benzylamine
- Phenylmethylamine
- Chlorobenzene
- Halobenzene
- Aralkylamine
- N-alkylpiperazine
- Aryl chloride
- Aryl halide
- 1,4-diazinane
- Piperazine
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Organoheterocyclic compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Hydrocarbon derivative
- Amine
- Organopnictogen compound
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Liquid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | 218 °C | Not Available | Water Solubility | 0.00025 g/L | Not Available | LogP | 7.1 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Buclizine EI-B (Non-derivatized) | splash10-014j-4930000000-3910923ac39cbf7127f8 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Buclizine EI-B (Non-derivatized) | splash10-014j-4930000000-3910923ac39cbf7127f8 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buclizine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0uxr-0396100000-056e751b0442b2816294 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buclizine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buclizine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buclizine 10V, Positive-QTOF | splash10-001i-0011900000-2904c41a951a983d9b1a | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buclizine 20V, Positive-QTOF | splash10-0f89-0194600000-8bc66356c5e64ce24c24 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buclizine 40V, Positive-QTOF | splash10-0ufr-1961000000-5bc3fa4151b81b78e4f5 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buclizine 10V, Negative-QTOF | splash10-001i-0000900000-af073b3b4eacca517bd5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buclizine 20V, Negative-QTOF | splash10-001i-0121900000-9c0d9b69b685143a9334 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buclizine 40V, Negative-QTOF | splash10-00lr-2932100000-a57e470264341e65aa24 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buclizine 10V, Negative-QTOF | splash10-001i-0000900000-2c494a70cf9be0036d7d | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buclizine 20V, Negative-QTOF | splash10-0f89-0120900000-59bef58fd7d232bd3303 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buclizine 40V, Negative-QTOF | splash10-0udi-2292100000-3e5613fff32ed793e3aa | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buclizine 10V, Positive-QTOF | splash10-001i-0030900000-d5e4b87f23e5b409c8b9 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buclizine 20V, Positive-QTOF | splash10-0udi-0090000000-b3a5da6a7f5dbcb874fe | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buclizine 40V, Positive-QTOF | splash10-0udi-1390000000-8d4cf39a76ba6410d0ae | 2021-09-23 | Wishart Lab | View Spectrum |
|
---|